Want to join the conversation?
U.S. FDA approves $AGN and Gedeon Richter's VRAYLAR (cariprazine) capsules. This drug will address the unmet need for the treatment of bipolar I disorder and schizophrenia in adults. In the U.S. alone around five million people are affected by these disorders and will benefit from this drug approval.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?